INBRX-106 - Hexavalent OX40 agonist antibody
Ph 1 Ph 2 INBRX-106
Phase 2 small_molecule active
Quick answer
INBRX-106 - Hexavalent OX40 agonist antibody for Solid Tumor is a Phase 2 program (small_molecule) at Inhibrx Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibrx Biosciences
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active